Listener feedback on the PISCES trial, AHA news (including a big PCSK9i trial), beta-blockers post MI, LAAC, and post-AF ablation OAC use are the topics John Mandrola, MD, discusses in this week's podcast. This podcast is intended for healthcare professionals only. To read a partial transcript or to comment, visit: https://www.medscape.com/twic I Listener Feedback Why I Believe Fish Oil's Big CV Benefit in Dialysis Patients https://www.medscape.com/viewarticle/why-i-believe-fish-oils-big-cv-benefit-dialysis-patients-2025a1000uzg PISCES trial ...
Listener feedback on the PISCES trial, AHA news (including a big PCSK9i trial), beta-blockers post MI, LAAC, and post-AF ablation OAC use are the topics John Mandrola, MD, discusses in this week's podcast.
This podcast is intended for healthcare professionals only.
To read a partial transcript or to comment, visit:
https://www.medscape.com/twic
I Listener Feedback
Why I Believe Fish Oil's Big CV Benefit in Dialysis Patients https://www.medscape.com/viewarticle/why-i-believe-fish-oils-big-cv-benefit-dialysis-patients-2025a1000uzg
- PISCES trial https://www.nejm.org/doi/full/10.1056/NEJMoa2513032
II PCSK9 Inhibitor News
In Global Trial, PCSK9 Inhibitor Provides Major Protection Against First CV Event https://www.medscape.com/viewarticle/global-trial-pcsk9-inhibitor-provides-major-protection-2025a1000uzp
- VESALIUS-CV trial https://www.nejm.org/doi/full/10.1056/NEJMoa2514428
- ODYSSEY trial https://www.nejm.org/doi/full/10.1056/NEJMoa1801174
- FOURIER https://www.nejm.org/doi/full/10.1056/NEJMoa1615664
- Anish Koka Tweet on LDL-lowering https://x.com/anish_koka/status/1987280506937909326?s=20
III Beta-Blockers After MI and John Cleland
- Beta-Blockers after MI with normal EF https://www.nejm.org/doi/full/10.1056/NEJMoa2512686
- REBOOT-CNIC trial https://www.nejm.org/doi/full/10.1056/NEJMoa2504735
- REDUCE AMI trial https://academic.oup.com/ehjcvp/article/9/2/192/6895544?login=false
- ABYSS trial https://www.nejm.org/doi/full/10.1056/NEJMoa2404204
- CAPITAL RCT trial https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0199347
- Beta-Blockers after MI with mildly reduced EF https://pubmed.ncbi.nlm.nih.gov/40897190/
- John Cleland Clinical Outlook https://www.nature.com/articles/s41569-025-01228-w
IV Left Atrial Appendage Closure – The CLOSURE-AF trial
Percutaneous LAAC in AF Falls Short Again in CLOSURE-AF https://www.medscape.com/viewarticle/percutaneous-left-atrial-appendage-closure-af-falls-short-2025a1000uzu
- Prague-17 Trial https://www.jacc.org/doi/10.1016/j.jacc.2020.04.067
- OPTION trial https://www.nejm.org/doi/full/10.1056/NEJMoa2408308
V Oral AC after AF ablation – the OCEAN Trial
Anticoagulation After AF Ablation: The OCEAN Trial Still Leaves Questions https://www.medscape.com/viewarticle/anticoagulation-after-af-ablation-ocean-trial-still-leaves-2025a1000v4t
- OCEAN Trial https://www.nejm.org/doi/full/10.1056/NEJMoa2509688
- ALONE-AF trial https://jamanetwork.com/journals/jama/fullarticle/2838294
You may also like:
The Bob Harrington Show with the Stephen and Suzanne Weiss Dean of Weill Cornell Medicine, Robert A. Harrington, MD. https://www.medscape.com/author/bob-harrington
Questions or feedback, please contact news@medscape.net
View more
